# GS-7977 With Ribavirin for Hepatitis C (SPARE)

> **NCT01441180** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** GS7977
- **DRUG:** RBV

## Key facts

- **NCT ID:** NCT01441180
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-03
- **Final completion:** 2014-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441180, "GS-7977 With Ribavirin for Hepatitis C (SPARE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01441180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*